Deoxycytidine diphosphate
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Deoxycytidine diphosphate | |
|---|---|
| Image:2'-Desoxycytidindiphosphat.svg | |
| Identifiers | |
| CAS number | |
| PubChem | |
| MeSH | |
| SMILES | Nc1ccn(C2CC(O)C(COP(=O)(O)OP(=O)(O)O)O2)c(=O)n1 |
| Properties | |
| Molecular formula | C9H15N3O10P2 |
| Molar mass | 387.177 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
Deoxycytidine diphosphate is a derivative of the common nucleic acid, cytidine triphosphate or (CTP), in which the hydroxyl or (-OH) group on the 2nd carbon of the nucleotide's pentose has been removed -- hence the deoxy- part of the name. The diphosphate of the name indicates that one of the phosphoryl groups of CTP has been removed, most likely by hydrolysis.
Deoxyguanosine diphosphate would be abbreviated dCDP.
See also
 | This biochemistry article is a stub. You can help WikiDoc by expanding it. |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
